Your browser doesn't support javascript.
loading
ANO1-downregulation induced by schisandrathera D: a novel therapeutic target for the treatment of prostate and oral cancers.
Park, SeonJu; Das, Raju; Nhiem, Nguyen Xuan; Jeong, Sung Baek; Kim, Minuk; Kim, Dongguk; Oh, Hye In; Cho, Su-Hyeon; Kwon, Oh-Bin; Choi, Jae-Hyeog; Park, Chul Soon; Kim, Song-Rae; Moon, Uk Yeol; Cha, Boksik; Choi, Dong Kyu; Lee, Sungwoo; Namkung, Wan; Woo, Joohan; Seo, Yohan.
Affiliation
  • Park S; Chuncheon Center, Korea Basic Science Institute, Chuncheon, Republic of Korea.
  • Das R; Department of Physiology, Dongguk University College of Medicine, Gyeongju, Republic of Korea.
  • Nhiem NX; Institute of Marine and Biochemistry, Vietnam Academy of Science and Technology (VAST), Hanoi, Vietnam.
  • Jeong SB; Graduate University of Science and Technology, Hanoi, Vietnam.
  • Kim M; New Drug Development Center, Daegu Gyeongbuk Medical Innovation Foundation, Daegu, Republic of Korea.
  • Kim D; Department of Medical Device Development Center, Daegu-Gyeongbuk Medical Innovation Foundation (KMEDI hub), Daegu, Republic of Korea.
  • Oh HI; Department of Medical Device Development Center, Daegu-Gyeongbuk Medical Innovation Foundation (KMEDI hub), Daegu, Republic of Korea.
  • Cho SH; Underwood Division Economics, Underwood International College, Yonsei University, Seoul, Republic of Korea.
  • Kwon OB; Chuncheon Center, Korea Basic Science Institute, Chuncheon, Republic of Korea.
  • Choi JH; New Drug Development Center, Daegu Gyeongbuk Medical Innovation Foundation, Daegu, Republic of Korea.
  • Park CS; New Drug Development Center, Daegu Gyeongbuk Medical Innovation Foundation, Daegu, Republic of Korea.
  • Kim SR; Department of Bio-nanomaterials, Bio Campus of Korea Polytechnics, Nonsan, Republic of Korea.
  • Moon UY; Chuncheon Center, Korea Basic Science Institute, Chuncheon, Republic of Korea.
  • Cha B; New Drug Development Center, Daegu Gyeongbuk Medical Innovation Foundation, Daegu, Republic of Korea.
  • Choi DK; New Drug Development Center, Daegu Gyeongbuk Medical Innovation Foundation, Daegu, Republic of Korea.
  • Lee S; New Drug Development Center, Daegu Gyeongbuk Medical Innovation Foundation, Daegu, Republic of Korea.
  • Namkung W; New Drug Development Center, Daegu Gyeongbuk Medical Innovation Foundation, Daegu, Republic of Korea.
  • Woo J; College of Pharmacy, Yonsei Institute of Pharmaceutical Science, Yonsei University, Incheon, Republic of Korea.
  • Seo Y; Department of Physiology, Dongguk University College of Medicine, Gyeongju, Republic of Korea.
Front Pharmacol ; 14: 1163970, 2023.
Article de En | MEDLINE | ID: mdl-37274097
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Front Pharmacol Année: 2023 Type de document: Article Pays de publication: Suisse
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Front Pharmacol Année: 2023 Type de document: Article Pays de publication: Suisse